subscribeSubscribe
price-trendAsk Us
AstraZeneca calls off two late-stage potassium drug trials

AstraZeneca calls off two late-stage potassium drug trials
REUTERS
02 Dec 2023
Share Share
LOKELMA Granted FTD by FDA in Chronic Hemodialysis With Hyperkalemia

LOKELMA Granted FTD by FDA in Chronic Hemodialysis With Hyperkalemia
BUSINESSWIRE
17 Nov 2021
Share Share
Lokelma label update approved in China for patients with hyperkalaemia

Lokelma label update approved in China for patients with hyperkalaemia
PRESS RELEASE
24 Nov 2020
Share Share
EU approves label update for AZ` Lokelma

EU approves label update for AZ` Lokelma
Selina McKee PHARMATIMES
04 May 2020
Share Share
Lokelma US label updated to include dosing guidance for hyperkalaemia

Lokelma US label updated to include dosing guidance for hyperkalaemia
ASTRAZENECA
27 Apr 2020
Share Share
China approves AstraZeneca`s Lokelma to treat hyperkalaemia

China approves AstraZeneca`s Lokelma to treat hyperkalaemia
BIOSPECTRUM ASIA
08 Jan 2020
Share Share
NICE turns down hyperkalaemia therapies

NICE turns down hyperkalaemia therapies
Selina McKee PHARMA TIMES
30 Oct 2018
Share Share
AZ gets US approval for Veltassa rival Lokelma

AZ gets US approval for Veltassa rival Lokelma
Phil Taylor PMLIVE
21 May 2018
Share Share
LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia

LOKELMATM Approved in the US for the Treatment of Adults with Hyperkalemia
BUSINESSWIRE
18 May 2018
Share Share
AstraZeneca`s Lokelma (Sodium zirconium cyclosilicate) Receives Approval In Europe

AstraZeneca`s Lokelma (Sodium zirconium cyclosilicate) Receives Approval In Europe
EMA
06 Apr 2018
Share Share